Epstein-Barr virus keratitis after a chemical facial peel.
Pflugfelder
S C
SC
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine.
Huang
A
A
Crouse
C
C
D000212:Acyclovir / Q000627:therapeutic use; D000368:Aged; D000956:Antigens, Viral / Q000097:blood; D002615:Chemexfoliation / Q000009:adverse effects*; D003315:Cornea / Q000382:microbiology; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000209:etiology*; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D007635:Keratitis, Dendritic / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D016133:Polymerase Chain Reaction; D014792:Visual Acuity
D000956:Antigens, Viral; D004279:DNA, Viral; C033305:Epstein-Barr virus early antigen; D000212:Acyclovir